Sulforaphane for Blood Sugar Regulation

Research suggests that sulforaphane, a compound found in broccoli and other cruciferous vegetables, may support blood sugar regulation and improve insulin sensitivity through several interconnected biological pathways, including activation of the antioxidant regulator Nrf2, modulation of inflammation via NFκB, beneficial shifts in gut microbiome composition, and downstream effects on glucose metabolism in liver and muscle cells. The evidence base includes two randomized controlled trials, multiple mechanistic cell and animal studies, and numerous reviews synthesizing preclinical and clinical findings, with the overall direction consistently supportive, though the strength of human evidence remains modest. A 2025 randomized controlled trial in adults with prediabetes found only a small, statistically significant reduction in fasting blood glucose that did not meet its prespecified clinical threshold, and a broad 2025 review of 84 registered clinical trials noted that results across studies have generally been limited by small sample sizes, inconsistent outcomes, and publication bias, with roughly half of completed trials remaining unpublished. Studies indicate that individual responses may vary meaningfully depending on gut microbiome composition and metabolic subtype, suggesting that sulforaphane's potential benefits for blood sugar control may not apply uniformly across all populations, and that larger, more rigorous human trials are needed before firm conclusions can be drawn.